Editorials

Boeing's third-quarter 2026 10-Q, filed October 27, 2026, shows operating income recovering to $354M from $156M in the second quarter, while gross profit kept falling and the company still reported a net loss. The operating line is the part of the story that looks better. The gap between that operating income and the net loss is where the quality of the recovery gets tested. Figures below are from the company's SEC filings; where the data does not explain a line, this piece says so.

Revenue rose from $22.22B in Q1 to $24.56B in Q2 and then eased to $24.19B in Q3. Gross profit moved the other way, from $2.55B to $2.41B to $2.17B. Cost of revenue rose by about $2.5B between Q1 and Q2 and then held roughly flat in Q3. So in the third quarter Boeing booked about $24.2B of revenue but kept only $2.17B after cost of revenue, versus $2.55B on $22.2B in the first quarter.

That is the gross-margin compression. The reported data does not break cost of revenue down by program, so this piece cannot say whether the squeeze came from mix, delivery timing, production inefficiency or charges. The question for a value investor is whether the gross line is recovering with volume. On these three quarters it is not.

Between Q2 and Q3, gross profit fell by $247M and R&D fell by about $91M. G&A fell by about $230M, from $1.43B back to $1.20B, which is the largest single driver. Those three items together account for only about $74M of improvement. Operating income actually rose by $198M, so roughly $124M came from operating line items that the reported data does not show.

The Q1-to-Q2 move shows the same pattern. Gross profit down $132M, G&A up $231M and R&D up $18M explain a decline of about $345M, while operating income fell about $292M. Again, about $50M is unexplained by the listed lines.

The reading is that the Q3 operating recovery came mostly from G&A coming back down to its Q1 level, not from better gross economics. A recovery built on an expense line that can swing this much from quarter to quarter is less durable than one built on gross profit. The unexplained residuals also mean the operating line has other moving parts the reported data does not itemise.

The gap between operating income and pre-tax income is the largest reason the bottom line stays negative.

• Q1 2026: operating income of $448M became pre-tax income of $26M, a gap of $422M. Other non-operating income of $194M offset part of it. About $228M is not itemised in the reported data.
• Q2 2026: operating income of $156M became a pre-tax loss of $365M, a gap of $521M. Other non-operating income of $79M and equity-method income of $32M offset part of it. About $632M is not itemised.
• Q3 2026: operating income of $354M became a pre-tax loss of $123M, a gap of $477M. Other non-operating income of $96M and an equity-method loss of $31M offset part of it. About $542M is not itemised.

The reported income-statement data does not include an interest expense line. Given Boeing's debt load, interest is the most likely candidate for most of the unexplained amount. The MD&A summary for fiscal 2025 reports total debt of $54.1B, with $8.5B short-term, so the financing cost is material. This piece does not state the interest figure because the data in hand does not contain it.

Q3 then carried a $7M tax benefit, which took the pre-tax loss of $123M to a net loss of $116M. Q2 carried a $63M tax expense on a pre-tax loss, which deepened the net loss to $444M.

Diluted EPS was −$0.11 in Q1, −$0.67 in Q2 and −$0.26 in Q3. These reconcile to the net loss attributable to common shareholders after preferred dividends of roughly $86–87M a quarter, divided by diluted weighted shares of 788.0M, 790.6M and 792.7M. The preferred dividend is a fixed charge against common holders each quarter. Share count has crept up about 0.6% from Q1 to Q3, so dilution is small in this window.

The per-share numbers therefore follow the same pattern as the net line. A quarter with positive operating income still leaves common holders with a loss, and the Q3 improvement in EPS is a narrowing of that loss rather than a move to profit.

The quarterly data support a narrower claim than a turnaround. Operating income has been positive in each of the three quarters, which is a real improvement on the 2025 quarters in the reported data, where operating results were distorted by large charges. But three things still block sustained profit at the net and per-share level:

1. Gross profit is falling while revenue is not. If volume keeps rising and gross profit keeps falling, the operating recovery depends on G&A and R&D cuts, which have limits.
2. Non-operating and financing items absorb most of the operating income. In Q3 they absorbed roughly $477M of a $354M operating profit, leaving a pre-tax loss.
3. The 2025 profit base is not clean. The MD&A summary attributes much of 2025's earnings from operations to a one-time $9.6B divestiture gain. Core operating earnings were $3.2B, and BCA still posted a $7.1B loss including $5.3B of reach-forward losses on the 777X and 767 programs.

For scenarios, the outcomes depend on three things the Q3 10-Q data cannot show on its own:

• If gross profit stabilises as deliveries rise, the operating line becomes less dependent on G&A swings, and the question moves to whether financing costs fall below operating income.
• If gross profit keeps falling into Q4, the operating recovery of Q3 looks like a one-quarter expense timing effect, and the net loss persists.
• If program charges or the SPEEA contract expiring in October 2026 bring new costs, the operating line is exposed again.

The 2025 MD&A also notes a plan to raise the 737 production rate from 42 to 47 per month in 2026, and continued 777X certification delays. Those are the operating variables to watch in the next filings.

This piece relies on reported income-statement figures for Q1–Q3 2026 and the fiscal 2025 MD&A summary. No 2026 segment data and no 2026 quarterly MD&A text were available, so the program-level causes of the gross-profit decline could not be checked. The interest expense line and the operating-expense items behind the roughly $50–$125M quarterly residuals were not in the data available for this piece. Any reader drawing conclusions on the Q3 operating-to-net bridge should pull the full 10-Q before relying on those amounts.